These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10833207)

  • 21. Influences of sildenafil on lung function and hemodynamics in patients with chronic heart failure.
    Guazzi M; Tumminello G; Di Marco F; Guazzi MD
    Clin Pharmacol Ther; 2004 Oct; 76(4):371-8. PubMed ID: 15470337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral sildenafil reduces pulmonary hypertension after cardiac surgery.
    Trachte AL; Lobato EB; Urdaneta F; Hess PJ; Klodell CT; Martin TD; Staples ED; Beaver TM
    Ann Thorac Surg; 2005 Jan; 79(1):194-7; discussion 194-7. PubMed ID: 15620942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb.
    Jaillard S; Larrue B; Deruelle P; Delelis A; Rakza T; Butrous G; Storme L
    Ann Thorac Surg; 2006 Mar; 81(3):935-42. PubMed ID: 16488698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erectile dysfunction in healthy subjects predicts reduced coronary flow velocity reserve.
    Borgquist R; Gudmundsson P; Winter R; Nilsson P; Willenheimer R
    Int J Cardiol; 2006 Sep; 112(2):166-70. PubMed ID: 16271777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of oral sildenafil citrate on intraoperative hemodynamics in patients with pulmonary hypertension undergoing valvular heart surgery.
    Shim JK; Choi YS; Oh YJ; Kim DH; Hong YW; Kwak YL
    J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1420-5. PubMed ID: 17140970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects.
    Mikhail GW; Prasad SK; Li W; Rogers P; Chester AH; Bayne S; Stephens D; Khan M; Gibbs JS; Evans TW; Mitchell A; Yacoub MH; Gatzoulis MA
    Eur Heart J; 2004 Mar; 25(5):431-6. PubMed ID: 15033256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial.
    Behling A; Rohde LE; Colombo FC; Goldraich LA; Stein R; Clausell N
    J Card Fail; 2008 Apr; 14(3):189-97. PubMed ID: 18381181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sildenafil citrate therapy for pulmonary arterial hypertension.
    Galiè N; Ghofrani HA; Torbicki A; Barst RJ; Rubin LJ; Badesch D; Fleming T; Parpia T; Burgess G; Branzi A; Grimminger F; Kurzyna M; Simonneau G;
    N Engl J Med; 2005 Nov; 353(20):2148-57. PubMed ID: 16291984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intratracheal administration of sildenafil and surfactant alleviates the pulmonary hypertension in newborn piglets.
    Obaid L; Johnson ST; Bigam DL; Cheung PY
    Resuscitation; 2006 May; 69(2):287-94. PubMed ID: 16500016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term effects of early administered sildenafil and NO donor on the cardiovascular system of SHR.
    Kristek F; Koprdová R; Cebová M
    J Physiol Pharmacol; 2007 Mar; 58(1):33-43. PubMed ID: 17440224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of nitroprusside and nitroglycerin on coronary blood flow in stenotic arteries: study in patients with single-vessel coronary artery disease.
    Gatzov P; Voudris V; Skoularikis J; Gentchev G; Manginas A; Cokkinos DV
    J Invasive Cardiol; 2008 Aug; 20(8):391-5. PubMed ID: 18688061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship.
    Garg N; Sharma MK; Sinha N
    Int J Cardiol; 2007 Sep; 120(3):306-13. PubMed ID: 17174417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic effects of sildenafil in patients with stable ischemic heart disease.
    Manfroi WC; Caramori PR; Zago AJ; Melchior R; Zen V; Accordi M; Gutierres D; Noer C
    Int J Cardiol; 2003 Aug; 90(2-3):153-7. PubMed ID: 12957746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of combined use of sildenafil citrate (Viagra) and 17beta-estradiol on ovine coronary and uterine hemodynamics.
    Zoma WD; Baker RS; Clark KE
    Am J Obstet Gynecol; 2004 May; 190(5):1291-7. PubMed ID: 15167832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure.
    Guazzi M; Tumminello G; Di Marco F; Fiorentini C; Guazzi MD
    J Am Coll Cardiol; 2004 Dec; 44(12):2339-48. PubMed ID: 15607396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of sildenafil on pulmonary embolism-induced oxidative stress and pulmonary hypertension.
    Dias-Junior CA; Souza-Costa DC; Zerbini T; da Rocha JB; Gerlach RF; Tanus-Santos JE
    Anesth Analg; 2005 Jul; 101(1):115-20, table of contents. PubMed ID: 15976216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.
    Lewis GD; Shah R; Shahzad K; Camuso JM; Pappagianopoulos PP; Hung J; Tawakol A; Gerszten RE; Systrom DM; Bloch KD; Semigran MJ
    Circulation; 2007 Oct; 116(14):1555-62. PubMed ID: 17785618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of sildenafil on coronary active and reactive hyperemia.
    Chen Y; Du R; Traverse JH; Bache RJ
    Am J Physiol Heart Circ Physiol; 2000 Nov; 279(5):H2319-25. PubMed ID: 11045968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sildenafil modulates hemodynamics and pulmonary gas exchange.
    Kleinsasser A; Loeckinger A; Hoermann C; Puehringer F; Mutz N; Bartsch G; Lindner KH
    Am J Respir Crit Care Med; 2001 Feb; 163(2):339-43. PubMed ID: 11179103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Avanafil, a highly selective phosphodiesterase type 5 inhibitor for erectile dysfunction, shows good safety profiles for retinal function and hemodynamics in anesthetized dogs.
    Mochida H; Yano K; Inoue H; Yee S; Noto T; Kikkawa K
    J Urol; 2013 Aug; 190(2):799-806. PubMed ID: 23321580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.